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Background: A cancer diagnosis elicits greater distress than any other medical diagnosis, and yet very few studies
have evaluated the efficacy of structured online self-help therapeutic programs to alleviate this distress. This study
aims to assess the efficacy over time of an internet Cognitive Behaviour Therapy (iCBT) intervention (‘Finding My
Way’) in improving distress, coping and quality of life for individuals with a recent diagnosis of early stage cancer of
any type.
Methods/Design: The study is a multi-site Randomised Controlled Trial (RCT) seeking to enrol 188 participants who
will be randomised to either the Finding My Way Intervention or an attention-control condition. Both conditions are
delivered online; with 6 modules released once per week, and an additional booster module released one month after
program-completion. Participants complete online questionnaires on 4 occasions: at baseline (immediately prior to
accessing the modules); post-treatment (immediately after program-completion); then three and six months later.
Primary outcomes are general distress and cancer-specific distress, with secondary outcomes including Health-Related
Quality of Life (HRQoL), coping, health service utilisation, intervention adherence, and user satisfaction. A range of
baseline measures will be assessed as potential moderators of outcomes. Eligible participants are individuals recently
diagnosed with any type of cancer, being treated with curative intent, aged over 18 years with sufficient English
language literacy, internet access and an active email account and phone number. Participants are blinded to
treatment group allocation. Randomisation is computer generated and stratified by gender.
Discussion: Compared to the few prior published studies, Finding My Way will be the first adequately powered trial to
offer an iCBT intervention to curatively treated patients of heterogeneous cancer types in the immediate post-diagnosis/
treatment period. If found efficacious, Finding My Way will assist with overcoming common barriers to face-to-face therapy
in a cost-effective and accessible way, thus helping to reduce distress after cancer diagnosis and consequently decrease
the cancer burden for individuals and the health system.
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Despite improvements in treatment and survival rates, a
cancer diagnosis continues to elicit greater distress than any
other medical diagnosis [1]. Research has consistently found
that 30 to 40 per cent of recently diagnosed patients experi-
ence clinically significant depressive or anxiety disorders
[2,3]. Distress is most acute during the first 12 months after
diagnosis, when a range of medical treatments take place,
following which the prevalence reduces to levels comparable
with the community [4]. Consequently, distress manage-
ment within the first 12 months after diagnosis has been
recognised as an integral component of a patient’s clinical
treatment [5,6]. Despite this, distress and psychiatric disor-
ders among cancer patients often go under-recognised and
untreated [7]. This particularly applies to the 30% of Austra-
lian cancer patients who reside in rural or regional areas,
where access to specialist cancer services is limited [6].
Psychological approaches that alleviate distress
Over the past two decades, a range of psychological inter-
ventions to alleviate distress have been empirically investi-
gated, predominantly among women with breast cancer.
Intervention research has focused on developing and evalu-
ating interventions that target the known psychological pre-
dictors of maladjustment [8], namely, low social support,
prior anxiety and depression (vulnerability to distress), and
maladaptive coping, particularly repression of emotions,
helplessness/hopelessness, and cognitive and behavioural
avoidance. Interventions tested have included those based
on Cognitive Behavioural Therapy (CBT) [9], Supportive
Expressive Therapy (SET) [10], psycho-educational pro-
grams [11], mindfulness-based therapy [12], and peer-
support groups [13]. There is clear meta-analytic evidence
that all of these conventional psychosocial interventions
are efficacious compared to control groups in facilitating
adjustment [14]; with large effect sizes (ES) found for de-
pression (ES = 1.2), anxiety (ES = 1.99), and functional ad-
justment / quality of life (QOL) (ES = 0.91) [14]. However,
CBT has the largest evidence base for treating cancer-
related distress to date [14], with most studies suggesting
that treatment for distress at the time of cancer diagnosis
is more effective than after cancer treatment has been
completed [11].
Need for novel approaches to improve access
While demonstrably efficacious, there several barriers to at-
tending face-to-face therapy in the Australian setting. First,
there are limited psychosocial services freely available in the
public health setting, with the current capacity not suffi-
cient to meet the demand [6]. This is particularly evident in
rural and remote areas where access to multidisciplinary
cancer care is problematic, and resulting inequities in
health outcomes are well recognised [6]. Second, even
when psychosocial services are offered in urban settings,research suggests that less than 25% of Australians attend
[15], with low attendance attributed to a variety of barriers
including: personal barriers, such as ongoing stigma associ-
ated with seeking mental health assistance [16,17], and
illness-related barriers such as patients’ reduced physical
capacity for additional appointments [17]. As a result of
these barriers, national government supportive care policies
have recognised that innovative methods of increasing ac-
cess to supportive care throughout the treatment trajectory
are required for all cancer patients [6].
One such innovative method of increasing patient ac-
cess to supportive care is through internet-based provision
of psychosocial services [16-18]. Since 2000 a plethora of
randomised controlled trials and systematic reviews have
examined internet-based interventions for both psycho-
logical [19,20] and physical [17,18] health complaints. Of
these interventions, self-guided web-based interventions
offer the particular advantage of overcoming the majority
of the barriers discussed above for both rural and urban
patients, along with anonymity, privacy and convenience
of progressing through a program at the user’s own pace.
Such interventions tend to be highly structured into mod-
ules, are derived from theory (predominantly cognitive be-
haviour therapy), and have been adapted from existing
evidence-based print-resources or face-to-face therapy
[21]. Consistent with research on face-to-face therapy,
internet Cognitive Behaviour Therapy (iCBT) interven-
tions have the largest evidence base for efficacy in improv-
ing both mental health conditions [22] and, increasingly,
coping with chronic physical health conditions [17,18].
Status of iCBT for cancer distress
Given that cancer consumers prefer multi-media to print
resources [23], and that 84% of Australians have access
to the internet [24], web-based interventions, and in par-
ticular iCBT-based interventions, appear a logical format
for the wide dissemination of psychological treatment
for cancer patients. However, the evidence-base for self-
guided iCBT-based psychological therapy in cancer is
only now emerging [25-28].
Two groups [26,28] developed and evaluated structured
self-guided online CBT-based coping programs for women
with recently diagnosed early-stage breast cancer. Similar in
design, their programs were both multi-component, and
contained 6–10 self-guided CBT-based modules, biomedical
information, links to other cancer resources and websites,
and asynchronous discussion boards. Both studies showed
evidence for the efficacy of their respective interventions:
The smaller of the two studies [28] found one significant
interaction where women with poorer baseline perceived
health status experienced greater improvements in perceived
health over time when assigned to the intervention, des-
pite a small sample and consequent lack of power. The
larger study [26] found the intervention was efficacious in
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negative mood, and reducing cancer-related post-traumatic
symptoms. However, as each of these studies involved only
breast cancer patients, efficacy could not be demonstrated
across cancer types.
In the third study, Duffecy et al. [27] ran a small RCT of
31 post-treatment survivors of various cancer types to
examine the feasibility and acceptability of an 8-week Inter-
net Support Group (ISG) combined with an Individual
Internet Intervention (III), compared with the III alone. The
study supported feasibility and acceptability of the combined
program, and found that both conditions produced large re-
ductions in depressive symptoms in participants with high
baseline distress. However, the study was underpowered to
detect improvement over time and time x treatment effects;
further, it examined efficacy in post-treatment survivors, ra-
ther than patients currently undergoing treatment. Current
CBT literature suggests that a more effective time to imple-
ment such interventions may be in the immediate post-
diagnosis period, when patients are likely to be experiencing
higher levels of distress generally [4].
Our research group was the first to pilot test a 6-week
iCBT program for people with any type of early stage/
curatively treated cancer, and designed to be delivered
soon after diagnosis [25]. In contrast to the previous
three programs which all depended on group-support as
a key feature, our study tested an individual self-guided
web-based intervention for newly diagnosed patients
that was independent of moderators and peer-support
components, and was therefore consistent with the large
evidence base for CBT [14]. Program content was de-
rived from our evidence-based print self-help breast can-
cer workbook [29], but heavily revised and expanded to
ensure relevance to heterogeneous cancer populations.
In a case-series design, participants (n = 12) were
assessed at baseline and after completing the program.
Analysis found the intervention led to reductions with
moderate associated effect sizes in negative affect, help-
lessness/hopelessness, anxious preoccupation, and fatal-
ism. Results therefore provided preliminary support for
the potential efficacy of the web-based CBT program for
improving cancer-related distress and anxious preoccu-
pation after cancer diagnosis. However, the pilot nature
of this study and small sample size meant that the effi-
cacy of the intervention compared with a control condi-
tion could not be established.
In summary, the four studies published to date provide
preliminary evidence of the feasibility of iCBT interventions
for delivering psychosocial interventions for coping with
cancer. However, studies examining the efficacy of iCBT
programs aimed at heterogeneous cancer types have so far
been limited by either (1) small sample sizes and conse-
quent lack of power, (2) lack of a control condition, and/or
(3) not providing analysis of the longer-term impact of theintervention. Further, only our group have investigated a
self-guided intervention that is (a) independent of discus-
sion board components and therefore truly self-guided and
(b) applicable to delivery soon after diagnosis, as opposed
to post cancer treatment, and therefore consistent with
CBT literature suggesting that treatment for distress at the
time of cancer diagnosis is more effective than treatment
for distress after treatment for cancer.
This paper reports on the protocol for the proposed
RCT to examine the effectiveness of the iCBT interven-
tion in a multisite setting.
Aims and hypotheses
This study aims to evaluate the efficacy of the next iter-
ation of our self-help internet cancer coping intervention
(‘Finding My Way’) in improving wellbeing and quality
of life of early-stage cancer patients over time, using a
multi-site RCT.
A secondary aim is to investigate moderators of thera-
peutic change, consistent with recommendations that
RCTs should identify who benefits most, and under what
conditions, from psychosocial interventions [30]. For the
present study, factors that have been previously shown
to predict distress will be examined for their potential to
moderate the effects of the intervention; namely, avail-
ability of social support, cognitive vulnerability to dis-
tress, and motivation to seek information [8,31].
Therefore it is hypothesised that:
1. Intervention participants will report greater
improvements compared to attention-control
participants in the primary outcome, distress, from
baseline to post-treatment and 3- and 6-month
follow-up;
2. Intervention participants will report greater
improvements compared to attention-control
participants in the secondary outcomes coping
and HRQOL over time;
3. Primary and secondary outcomes will be moderated
such that
a. The significant changes over time in distress
between groups will be moderated by social
support, cognitive vulnerability to distress, and
motivation to seek information, and
b. The significant changes over time in coping and
HRQOL between groups will be moderated by
social support, cognitive vulnerability to distress,
and motivation to seek information.Methods/Design
Study design
Finding My Way (FMW) is a national level multi-site ran-
domised controlled trial registered with the Australian and
New Zealand Clinical Trials Registry with the registration
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duct the study has been sought and obtained from the
Southern Adelaide Clinical, Royal Brisbane and Women’s
and ACT Health Human Research Ethics Committees. Ran-
domisation occurs at the patient level: patients are rando-
mised to receive either the FMW intervention or an online
attention-control. Procedural elements of this study follow
CONSORT guidelines [32]. Attrition is monitored and rea-
sons for non-participation and withdrawal are recorded in
each arm. Data extraction and entry will be performed by
research team members blinded to group allocation.
Setting
Participation in the study occurs entirely online. The
web-program is hosted by Flinders University (www.fin-
dingmyway.org.au), with Flinders University as the ad-
ministering institution.
Participants
Inclusion criteria
Patients are eligible to participate if they have been diag-
nosed with any cancer (e.g., breast, prostate, colorectal,
testicular, lymphomas, haematologic or gynaecologic
malignancies); their cancer is being treated with curative
intent; they are currently receiving active cancer treat-
ment (surgery, chemotherapy, radiotherapy), or, if they
received surgery alone, have been diagnosed within the
last six months; they are aged 18 years or over; and they
have sufficient English language literacy to understand
the information sheet and consent form and navigate
the website, access to the internet (home or work), and
an active email address and phone number.
Exclusion criteria
Patients are ineligible to participate if they have a diag-
nosis of advanced cancer.
Withdrawal criteria
Patients who opt to withdraw from the study are asked if
they would consent to continue completing follow-up
measures, and for any existing data to be included in ana-
lyses. If consent is not given, their data will be erased from
the database along with any documentation related to
their involvement.
Recruitment
An overview of recruitment and enrolment processes is pro-
vided in Figure 1. Participants are recruited from Australian
hospitals and cancer centres according to any of the follow-
ing methods:
1. Self-referral: Participants self-refer to the website in
response to advertisements placed in local and na-
tional newspapers, on websites or in newsletters ofcancer agencies or support networks, or in waiting
areas of cancer agencies and clinics of participating
hospitals.
2. Direct approach: Potential participants are
approached directly by cancer clinicians or research
assistants at participating hospitals, and are given a
flyer containing a brief overview of the program and
the website address. Verbal consent is obtained at
this time for the research coordinator to provide
either (i) a single reminder phone call, during which
the research coordinator provides further
information about the study and obtains the
participants’ email address in order to send a direct
link to the website, or (ii) when the patient cannot
be contacted by phone, a single reminder letter
providing further information about the study
including the website address.
3. Letters of invitation: Letters printed on the site’s
letterhead and signed by the department head are
sent to patients missed in clinic. These letters ask
patients to consider participation and allow contact
by the researchers (via an opt-out response slip). A
single reminder phone call is then made to all pa-
tients invited to take part in the study if they do not
respond to the invitation letter after two weeks.
Protocol at some sites requires that a clinician/ re-
search assistant from the recruiting hospital contacts
the patient to obtain verbal consent for patient de-
tails to be provided, prior to contact by the research
coordinator.
Enrolment
Participants follow the email link or type in the web ad-
dress in order to access the website and register for the
program. Registration generates an automatic email to
the participant containing a link to activate their ac-
count. Following account activation, participants are di-
rected to read an online information page and consent
form. Eligibility criteria are clearly highlighted on the in-
formation page, and consent requires participants to
check a box stating they do not have advanced cancer.
Consent is obtained by the participant clicking on an “I
agree” button on the online consent form.
Following the consent process, participants complete the
baseline questionnaire. Participants are then randomised to
either the intervention or attention-control condition and
are directed to a welcome tutorial and their user home
screen, from which they are able to access their first mod-
ule immediately. Participants work through 6 modules: one
new module is accessible each week, along with previously
accessed modules. The order of module release is self-
determined during a goal-setting exercise conducted when
first logging into the program, which allows participants to
identify which topics are most immediately relevant to
Figure 1 Flow chart of study.
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become more relevant as participants progress through the
program. Participants receive automated email reminders
to use the program each week. A booster module, com-
prised of a summary of the key information points from
the program and links back to topics and worksheets, is ac-
cessible one month later. The opportunity to provide quali-
tative and quantitative feedback is provided at the end of
each module.
Randomisation
This study is a parallel RCT, with equal numbers of partici-
pants randomised to the intervention and control arms.
Randomisation is automated within the website; the ran-
dom allocation sequence is generated by a researcher
blinded to the identity of participants using computer-
generated random numbers, and allocation is then auto-
mated by the website in a 1:1 ratio. Randomisation is strati-
fied by gender.
Blinding
Participants are blinded to their intervention assignment;
while they are aware there are two different versions of
the website (explained as ‘information’ and ‘activities’ ver-
sions), they are not informed that one is a ‘control’ condi-
tion, are not aware which is the primary intervention
being evaluated, and are blinded as to their own treatment
group allocation. A list of blinded participant details is ac-
cessible to the research assistant for the purposes of con-
ducting reminders about follow-up surveys.
Intervention and control arms
Intervention
Finding My Way is a 6-week password-protected CBT
internet application comprised of three main components:
(1) psycho-education, (2) cognitive-behavioural work-
sheets/strategies including worksheets, quizzes, relaxation
and meditation exercises, and (3) survivor testimonials.
Each week a new module is released to participants, andTable 1 Finding My Way content
Module Topics covered
Starting treatment Working with your medical team, treatment plannin
Physical symptoms Coping with side effects including fatigue, pain, ins
Emotional distress The emotional rollercoaster, including depression a
anger and stress
Identity Concerns regarding body image, loss or changes in
identity, intimacy and sexuality
Family & Friends The range of support concerns that arise, including
support people, impact on children and partners
Completing treatment Commencing preventative health behaviours, follow
Booster Summary of key themes from previous 6 topics.
Links back to key webpages.participants can continue referring back to previous mod-
ules throughout the study.
The 6 modules address: (i) starting treatment – working
with your medical team, covering assertive communication
and decision making, (ii) coping with physical symptoms
and side effects – including fatigue, pain, insomnia, and
provides activity pacing worksheets, and relaxation audio-
tracks; (iii) coping with emotional distress – which covers
depression, anxiety, anger and stress, and provides cognitive
restructuring diaries, and mindfulness audio-tracks; (iv)
body image, identity and sexuality – with psychosexual
worksheets, and therapeutic writing activities; (v) your fam-
ily and friends – comprising further assertive communica-
tion and needs assessment worksheets; and (vi) completing
treatment, which includes self-management strategies to fa-
cilitate healthy lifestyles.
A private online note-taking feature, mood monitor-
ing/management, and a resource section with links to
reputable cancer-related organisations and other health
websites are also available throughout the duration of
the program. The program is outlined in Table 1.Attention control
An information-only version of Finding My Way, developed
to provide an appropriate attention control for the study,
covers the same 6 module topics without any of the work-
sheets, activities, relaxation exercises, or note-taking feature.
Our previous research indicates that an attention control
condition does not significantly reduce distress [29], and
provides a more rigorous test of the intervention.Outcomes
Primary, secondary and moderator outcomes are assessed
using online self-report questionnaires. Baseline question-
naires are completed upon enrolment/ prior to randomisa-
tion. Post treatment questionnaires are completed at the
conclusion of the sixth module (seven weeks after complet-
ing the baseline survey), and follow-up questionnaires areWorksheet/Activities
g Assertive communication, Decision making
omnia Activity pacing, Relaxation exercises
nxiety, Cognitive restructuring, Mindfulness exercises,
Therapeutic writing
perceived Psychosexual worksheets, Therapeutic writing
identifying Assertive communication, Needs assessment
-up care planning Self-management, Goal setting
Links back to key worksheets (goal setting,
cognitive restructuring, relaxation, communication).
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treatment completion.
Primary outcome: distress
The primary outcome for this study is distress, measured
as general distress and as cancer-specific distress. Gen-
eral distress is measured using the total scale score of
the 21-item Depression Anxiety Stress Scale – short
form (DASS: [33]), which assesses levels of anxiety, de-
pression and stress over the previous week on a four-
point scale ranging from (0) Did not apply to me at all
to (3) Applied to me very much, or most of the time.
Cancer-specific distress is measured using the 17-item
Posttraumatic Stress Scale-Self Report [34], which mea-
sures on a 4-point scale (0 = Not at all or only one time,
3 = 5 or more times per week / almost always), the sever-
ity of each DSM-IV post-traumatic stress disorder symp-
tom criterion in terms of how often respondents
experienced each symptom in the previous week. For
this study, the measure was adapted in order to reflect
cancer diagnosis as the stressor.
Secondary outcomes
Secondary outcomes for this study include Health-Related
Quality of Life (HRQOL), coping, and the economic impact
of the intervention in terms of Health Service Utilisation.
HRQOL is measured using the European Organisation for
Research and Treatment of Cancer Quality of Life Core
Questionnaire [35], a 30-item comprehensive health related
quality of life assessment for cancer patients which yields a
global QOL score, and five functional subscales (physical,
emotional, social, role, cognitive).
Coping is measured with the mini-Mental Adjustment
to Cancer Scale (mini-MAC: [36]), a 29-item scale yield-
ing 5 factors: Fighting Spirit, Helplessness/Hopelessness,
Anxious Preoccupation, Fatalism, and Cognitive Avoid-
ance. Items are responded to on a 4-point scale ranging
from ‘definitely does not apply’ to ‘definitely does apply’.
Health Service Utilisation is examined using the 17-item
Health Service Utilisation Questionnaire [37], which as-
sesses health service use in the previous 12 months in
terms of whether patients have been hospitalised and the
number of visits to doctors and other health professionals.
Hospitalisation is indicated as no/yes day only/yes spent at
least one night (with number of days then recorded). Visits
to GPs/hospital doctors/specialist doctors are indicated on
a 7-point scale ranging from none to 25 or more times,
and utilisation of other health professionals (e.g. physio-
therapist) is indicated as yes or no.
Moderators of outcomes
Participant and medical characteristics, availability of so-
cial support, information-seeking preferences, emotion
regulation, vulnerability to cancer-distress, adherence tothe program, and participant satisfaction are assessed as
postulated moderators of program efficacy.
Participant and medical characteristics are assessed at
baseline only, and consist of age, marital status, occupational
status, annual gross income, level of educational attainment,
area of residence (rural/urban, state), ethnicity, cancer type,
time since diagnosis, treatment received (surgery, chemo-
therapy, radiotherapy, hormonal therapy, other), any other
chronic health conditions, and other support-services
accessed.
Availability of social support is assessed using the 20-
item Medical Outcome Study Social Support Survey [38],
which consists of four subscales: emotional/informational,
tangible, affectionate, and positive social interactions, with
availability of the support type listed in each item rated on
a 5-point scale (1 = none of the time, 5 = all of the time).
Information seeking preferences in terms of the type
and amount of cancer information sought by patients is
measured by the Miller Behavioral Style Scale scale [39].
This scale identifies information seekers who look for
and amplify threat-related cues (monitors) and distrac-
ters who avoid and minimize such cues (blunters), and
has been used extensively in cancer populations. The
scale asks the respondent to imagine two stress-evoking
scenarios, each of which is followed by eight statements
that describe different ways of coping with the stressor,
with four statements being of a monitoring or
information-seeking variety and four of a blunting or
information-avoiding variety. Respondents are asked to
check all statements that apply to them.
Vulnerability to distress is assessed using the Difficulties
in Emotion Regulation Scale [40], a 36-item measure of dif-
ficulties in emotion regulation across six dimensions,
namely a) lack of awareness of emotional responses, b) lack
of clarity of emotional responses, c) non-acceptance of
emotional responses, d) limited access to emotion regula-
tion strategies perceived as effective, e) difficulties control-
ling impulses when experiencing negative emotions, and f)
difficulties engaging in goal-directed behaviours when
experiencing negative emotions. Participants respond to
each item on a 5-point scale (1 = almost never, 5 = almost
always).
Adherence to the study is measured in two ways. First,
the self-help compliance scale [41] measures participant
self-reported engagement with program’s (i) information,
(ii) worksheets, and (iii) weekly time usage. Second, web-
site use indicators are tracked on the website itself, in-
cluding: number of visits, length of time logged in, and
number of modules and worksheets completed.
Finally, levels of satisfaction with the website will be
assessed as a measure of whether this intervention im-
proved psychosocial support for patients. Qualitative
feedback will be gathered within the website, and at
follow-up assessments.
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Sample size
Longitudinal sample size calculation for repeated measures
was conducted using a program developed by Hedeker
[42]. Previous online interventions targeting distress in
community samples have effect sizes ranging from .42 to
.65 for depression, and from .29 to 1.74 for anxiety [19].
Therefore, a conservative small-to-moderate effect size was
selected for the current study. Based on the pilot RCT find-
ings, an attrition rate of 21% at each of the assessment
points can be expected [29]. Thus for a study with 2 groups
and 4 assessment points, power set at 0.80, statistical sig-
nificance set at α = .05 (two tailed), total attrition set at
21%, an effect size set at 0.35 SD, and an expected primary
endpoint standard deviation of 4.0 at each time point [43],
94 participants per group are required, summing to a total
sample of 188 participants.
Statistical analysis
Quantitative data will be analysed using the Statistical
Package for the Social Sciences (SPSS) Version 17.0.
Baseline differences between groups will be investigated
using t-tests for continuous measures and χ2 tests of in-
dependence for categorical measures. Linear Mixed Ef-
fects Models (LMEM) will be employed to examine the
efficacy of the intervention. The LMEM calculates a re-
gression line for each individual while controlling for
baseline observation (fixed main effects). Baseline obser-
vations will be entered as covariates to eliminate the in-
fluence of baseline variability, resulting in a 2 (group:
intervention; control) X 3 (time: post-program; 3-month
follow-up; 6 month follow-up) fixed effects model for
each outcome variable, with random effects accounting
for individual variation. This approach effectively equal-
ises conditions at baseline and consequently allows for
direct comparison between conditions at each follow-up
point. In this context, (a) interactions between condition
and time, (b) main effects of group and (c) post-hoc
pairwise comparisons at each follow-up point are all in-
dicators of intervention effects. This analysis offers the
benefit of estimation maximisation; it provides joint
modelling for each participant of observed and missing
data based on maximising likelihood for population pa-
rameters as a function of the observed data. LMEM ana-
lyses are therefore robust with respect to handling
missing data and unbalanced designs in longitudinal re-
search as all participants with at least one observed post-
treatment data point are included. That is, as baseline
data is entered as a covariate, participants who do not
complete any of the post-program assessments are not
retained. To overcome this limitation and ensure this
trial adopts a fully intention-to-treat design, multiple im-
putation will be performed for participants with only
baseline-data. Therefore all participants, regardless ofmissing data at one or more assessment points, will be
included in analyses and accurate parameter estimates
obtained. Within-group effect sizes and reliable change
indices will be calculated to provide a measure of the
magnitude and clinical significance of changes respect-
ively. To test for moderation, separate LMEM analyses
will be conducted for each combination of moderator
and outcome variable, where the moderator and group
are entered in model 1 to control for main effects. The
product term is then entered in model 2, to represent
the interaction between group and moderating variable,
and will indicate the moderating effect.
Discussion
Internet-based self-help modalities represent one means
of overcoming existing barriers to cancer patients acces-
sing supportive care and psychosocial services, including
the lack of such services within the public health system,
particularly for rural patients, and barriers to attendance
even where such services are provided. However, previ-
ous studies examining the efficacy of web-based self-
help modalities for cancer populations have suffered
from a range of limitations including (1) lack of an
established psychological model (such as CBT) as the
basis for the program, (2) lack of a control condition (3)
small sample size and consequent lack of power for ana-
lyses, (4) lack of follow-up analysis over time, (5) exam-
ining efficacy of programs for one cancer type (i.e. breast
cancer) only, as opposed to heterogeneous cancer types,
and/or (6) examining programs implemented after com-
pletion of cancer treatment, as opposed to soon after
diagnosis when distress tends to be highest and psycho-
logical treatment most warranted.
To our knowledge, Finding My Way is unique in offer-
ing an iCBT intervention applicable to individuals with
heterogeneous cancer types soon after diagnosis. The
large scale of this national multi-site RCT will therefore
enable examination of the efficacy of such a program in
reducing patient distress, improving coping and health
related quality of life, and reducing health service utilisa-
tion in individuals with a range of cancer diagnoses. Fur-
thermore, this study offers the important contribution of
evaluating potential moderators of change. This infor-
mation can be of benefit clinically when determining
who to refer for online-interventions (versus who may
be more suitably treated via other modalities) as well as
benefitting future research via the refinement of inclu-
sion and exclusion criteria, improving trial stratification
and increasing power [30]. Indeed, it has been suggested
that results of treatment trials are often weak because
moderators of treatment are not examined, thus they
should be part and parcel of any treatment study [30];
however, few studies have specifically examined modera-
tors of psycho-oncology interventions.
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important means of overcoming common barriers to face-
to-face therapy in a cost-effective and accessible way, which
may particularly assist those residing in rural/remote areas.
Integration of such a program into the supportive care of-
fered to cancer patients within the health system will there-
fore be a promising avenue for reducing patient distress
after cancer diagnosis, and consequently for decreasing the
cancer burden both on individuals and within the health
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